Latest news
Press Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - CRISPR Medicine NewsCRISPR Medicine News · Fri, 07 Aug 2026 05:50:43 GMTTango Therapeutics Announces Executive Chair Transition - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 22:24:09 GMTINmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:56 GMTClimb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:19:18 GMTSatellite Bio Wins FDA IND Clearance for SB-101, Marking Transition to Clinical-Stage Company - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 16:02:37 GMTQ32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - TradingViewTradingView · Wed, 05 Aug 2026 10:59:00 GMTForlong Biotechnology Announces Approval to Initiate Phase I Clinical Trial of FL115 (IL-15 Superagonist) Subcutaneous Injection in Australia - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:14 GMTSatellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company - BioSpaceBioSpace · Wed, 05 Aug 2026 03:09:09 GMT